E

Emulate, Inc.

129 employees

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Understanding Disease
Medical
Emulating Human Biology
Life Science
Precision Medicine
Personalized Health

Date founded

2014

Funding rounds raised

Total raised

$82M

from 28 investors over 28 rounds

E

Emulate, Inc. raised $82M on September 7, 2021

Investors: Northpond Ventures and Perceptive Advisors

E

Emulate, Inc. raised undisclosed on March 6, 2020

Investors: Alumni Ventures Group, Founders Fund and Northpond Ventures

E

Emulate, Inc. raised $19M on March 6, 2020

Investors: Alumni Ventures Group

E

Emulate, Inc. raised $28M on August 1, 2019

Investors: Ethos Financial Group, LLC

E

Emulate, Inc. raised $36M on June 18, 2018

Investors: Starlight Ventures, GlassWall Syndicate, SciFi VC, Beyond Impact VC, Founders Fund and ALS Investment Fund

E

Emulate, Inc. raised $2M on June 20, 2017

Investors: National Institutes of Health

E

Emulate, Inc. raised $17M on October 20, 2016

Investors: OS Fund, Cedars-Sinai, ALS Finding a Cure®, ATEL Securities Corporation, +ND Capital, CSC Upshot Ventures and Techammer

E

Emulate, Inc. raised $28M on March 28, 2016

Investors: Labcorp, ATEL Securities Corporation, Blue Ivy Ventures, Techammer and OS Fund

E

Emulate, Inc. raised $12M on July 28, 2014

Investors: Cedars-Sinai and +ND Capital

FAQ